Pediatric sweet syndrome: case report and literature review

James Halpern1, Asad Salim

  • 1Department of Dermatology, University Hospital of North Staffordshire, Stoke-on-Trent, United Kingdom. james_halpern@hotmail.com

Pediatric Dermatology
|August 20, 2009
PubMed

Insights

Sweet syndrome in children typically follows an infection. Young children under 3 rarely have associated cancers, unlike older children, and respond well to steroids. Serious complications can occur.

Area of Science:

  • Pediatric Dermatology
  • Hematology
  • Immunology

Background:

  • Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is an inflammatory condition.
  • It is characterized by fever, neutrophilia, and a distinctive skin rash.
  • While often associated with hematologic malignancies in adults, its presentation and associations in children differ.

Purpose of the Study:

  • To describe a case of pediatric Sweet syndrome following an upper respiratory tract infection.
  • To conduct a comprehensive literature review of pediatric Sweet syndrome cases.
  • To analyze age-related differences in presentation, associations, and outcomes of pediatric Sweet syndrome.

Main Methods:

  • Case report of an 18-month-old boy with Sweet syndrome.
  • Systematic literature review of 66 reported pediatric Sweet syndrome cases.
  • Comparative analysis of cases based on age (under vs. over 3 years).

Main Results:

  • The case presented with typical Sweet syndrome features post-infection and responded to oral prednisolone without evidence of malignancy.
  • Literature review identified 66 pediatric cases.
  • Cases under 3 years showed male predominance and no malignancy association, contrasting with older children who had equal sex distribution and strong links to myeloid malignancies.

Conclusions:

  • Pediatric Sweet syndrome can present typically after infections and is treatable with corticosteroids.
  • Age is a critical factor in the clinical presentation and associated risks of Sweet syndrome in children.
  • While generally less severe than in adults, pediatric Sweet syndrome carries significant risks, particularly cardiovascular involvement, with a notable mortality rate.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Taste Buds and Receptors01:20

Taste Buds and Receptors

Gustation, or the sense of taste, is intrinsically linked to the anatomical structures located on the tongue. This organ's surface, along with the entirety of the oral cavity, is adorned with stratified squamous epithelium. Evident on the tongue are elevated structures known as papillae (singular = papilla), which house the mechanisms for the transduction of gustatory stimuli. Four distinct types of papillae exist, each identified by their unique morphological attributes: the circumvallate,...